April 2025 in “European Psychiatry” This systematic review and meta-analysis found that mood stabilizers used for bipolar disorder, such as lithium, valproate, carbamazepine, and lamotrigine, resulted in varying prevalence of dermatologic side effects, with lamotrigine showing the highest rash incidence, while severe reactions were rare.
March 2025 in “JEADV Clinical Practice” This article explores the role of ketoconazole shampoo in hair care beyond treating dandruff and seborrhoeic dermatitis, suggesting it may reduce hair shedding and chronic scalp inflammation, potentially complementing treatments for androgenetic alopecia.
February 2025 in “Vestnik dermatologii i venerologii” This case report describes a 47-year-old patient with scarred alopecia diagnosed as discoid lupus erythematosus, where treatment with multiple medications led to clinical improvement.
January 2025 in “Journal of Thu Dau Mot University” This study found that post-kidney transplant patients generally lacked disease knowledge, but good compliance behavior was associated with better knowledge, perceived susceptibility, and higher education levels.
This study reported that 72% of topical minoxidil users experienced adverse effects, such as scalp irritation and facial hypertrichosis, although only 20% discontinued treatment, indicating that longer use may improve tolerance despite initial side effects.
This research observed that in a prospective case series of 11 women with androgenetic alopecia, oral spironolactone improved hair thinning in most patients over 6 to 36 months, with mild side effects reported. However, effectiveness may be limited in advanced cases.
January 2025 in “Global Journal of Medical Therapeutics” In this case report, a 28-year-old female developed allergic contact dermatitis from prolonged use of 5% topical minoxidil, suggesting that minoxidil itself may often be responsible for such reactions rather than propylene glycol.
January 2025 in “Dermatology and Therapy” This review updates dermatologists on both FDA-approved and off-label hormonal therapies, including combined oral contraceptives, clascoterone, and spironolactone, used for acne treatment, providing insights into emerging approaches for managing the condition.
January 2025 in “Annals of Dermatology” This study observed that although most patients recognize SMP as a medical procedure requiring physician oversight, many still receive treatment outside medical settings, underscoring the need for expanded access to physician-led services, enhanced public education, and strengthened regulatory enforcement for patient safety.
December 2024 in “Indonesian Journal of Tropical and Infectious Disease” In a tropical, high-burden region, this study found that tinea corporis and tinea cruris were the most common types of dermatophytosis, particularly affecting female adults, and that treatment commonly involved griseofulvin and ketoconazole cream, with Trichophyton mentagrophytes as the prevalent pathogen.
December 2024 in “PubMed” This study evaluates the compatibility of six active pharmaceutical ingredients, including finasteride and spironolactone, with TrichoFoam™, a foam vehicle used in personalized treatments for alopecia, though it does not report specific results.
December 2024 in “Medical alphabet” In this study, 20 patients with telogen alopecia showed reduced hair loss and improved hair quality after 9 weeks of treatment with the topical product "Time to Grow" and the dietary supplement "Thick and Strong Hair.
November 2024 in “Skin Health and Disease” This review suggests that while minoxidil is effective in promoting hair growth, its precise mechanism remains unclear, and it may have emerging applications in treating various dermatological conditions.
August 2024 in “Nutrients” This study found that a combination of probiotic strains of Lactiplantibacillus administered over 16 weeks reduced the number and density of telogen hairs in individuals with androgenic alopecia, while increasing the abundance of Lactobacillus in their gut microbiota.
August 2024 in “Medicine” This study found that medroxyprogesterone acetate and ethinyl estradiol with drospirenone were the most frequently prescribed medications for PCOS, with some patients experiencing drug changes or discontinuation due to side effects or therapeutic failure.
This protocol outlines a study to evaluate whether photobiomodulation, alone or with melatonin, promotes hair regrowth in dogs with Alopecia X, reporting no new results yet.
April 2024 in “Current journal of applied science and technology” This study developed an ointment from palm kernel oil and shea butter, which demonstrated improved hair growth in rabbits and may inform the creation of non-harmful hair growth products for humans.
March 2024 in “Journal of the Dermatology Nurses’ Association” This review examines the off-label use of low-dose oral minoxidil for treating alopecia, comparing it to topical minoxidil and discussing potential risks, benefits, and side effects, as well as nursing considerations for patient care.
January 2024 in “Authorea (Authorea)” This study found that Sudanese epilepsy patients prioritize medication intake despite cosmetic effects from antiepileptic drugs, which may be influenced by cultural perceptions unique to the population.
January 2024 in “Editora In Vivo eBooks” This study reports a case of dermatophytosis, a zoonotic fungal infection, in an eleven-month-old spayed female dog, characterized by alopecia on the neck and ear, highlighting the condition's prevalence in hot, humid climates.
December 2023 in “Перспективи та виклики теоретичної медицини” This review compares modern hair transplantation techniques, including FUT and FUE, and highlights the potential of newer methods like robotic restoration and laser therapy to improve outcomes.
November 2023 in “Journal of the American Society of Nephrology” This report discusses two cases of kidney transplantation in transgender patients and highlights the complexities of managing gender-affirming care alongside post-transplantation health, including hormone therapy and associated risks.
October 2023 in “Journal of Mind and Medical Sciences” In this study, metabolic surgery led to a weight loss of 10.8 to 12.6 kg and improvement in body composition and HbA1c levels among patients from North-Eastern Romania, with nutritional intervention proving safe over six months.
July 2023 in “JAAD International” This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
June 2023 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This review discusses various therapies for androgenetic alopecia, highlighting minoxidil, finasteride, and PRP as effective and widely accessible options, but reports no new clinical results.
June 2023 in “Acta Scientifci Nutritional Health” This study found that children with celiac disease who adhered to a gluten-free diet experienced significant improvements in height, weight, and symptoms like diarrhea and abdominal pain, although cases of abdominal distention increased.
February 2023 in “Sibirskij onkologičeskij žurnal” In this review, chemotherapy-induced alopecia in cancer patients is linked to drug pharmacology, genetics, and nutrition, affecting patients' mental health; scalp cooling is highlighted as an effective prevention method, but more research is needed for broader solutions.
January 2023 in “Editora Enterprising eBooks” This collection presents interdisciplinary research aimed at advancing social development in Brazil, showcasing diverse academic contributions but does not report new empirical findings.
January 2023 in “Editora Enterprising eBooks” This publication compiles interdisciplinary research discussions contributing to social development in Brazil by addressing pertinent societal issues, but it reports no new research findings.
January 2023 in “Editora Enterprising eBooks” The document discusses various research topics relevant to Brazil's social and scientific development.